One of the molecular mechanisms through which cathepsin K contributes to breast cancer progression is by activation of ECM degrading matrix metalloproteinases, which enhances the invasiveness and metastatic capacity of breast cancer cells [97]. The gene discussed is CTSK; the disease is breast carcinoma.